50
Participants
Start Date
January 1, 2026
Primary Completion Date
May 31, 2027
Study Completion Date
May 31, 2027
provider order set/order panel
Triple testing order panels will be built specifically for this study. An order for a screening blood test for any of the three bloodborne viruses (BBVs; i.e. HIV, hepatitis B virus (HBV), or hepatitis C virus (HCV)) will be coupled with orders for the respective screening blood tests for the other two BBVs to be selected by default in a single order panel. These order panels will only be available to participating providers during their participation in the intervention arm.
University of Texas Southwestern Medical Center, Dallas
Collaborators (1)
Gilead Sciences
INDUSTRY
University of Texas Southwestern Medical Center
OTHER